By screening a series of carbon nanomaterials, it was found that the two-dimensional graphdiyne oxide (GDYO) exhibited an anti-leukemia effect specifically against the DNMT3A-mutant AML cells. This evidence concerns the gene DNMT3A and acute myeloid leukemia.